solid start year impact manag reiter ow
morn report result beat expect top bottom
line despit late quarter covid-headwind growth driver urolift expect
signific pressur next coupl month howev manag believ
uniqu clinic attribut high outpati procedur mix profit profil clinician
provid incent bring procedur back on-line soon possibl
tend agre compani number push pull factor impact
busi includ product use support covid help cushion
potenti soft come quarter two begin process return top-
tier larg cap growth consequ reiter overweight rate
first quarter sale ep come ahead
expect compani urolog respiratori vascular access busi
post highest growth quarter latter two actual benefit
covid situat intervent urolog growth approxim roughli line
compani outlook year pre-covid ep came ahead street
due top-line beat tighter opex cost control lower project tax rate
formal guidanc provid compani provid guidanc
comment specif base case procedur resumpt manag
note expect intervent urolog follow intervent access surgic
come back quickli
point call unsurprisingli key focu call
perform pace recoveri urolift compani import growth
driver manag note product outpac expect grow
januari februari drop significantli last two week
march compar jan-feb level entir month march
doubt like soft busi line manag believ
first busi come back case perform asc/
offic set expect recov first addit note hour
same-day discharg procedur one econom attract procedur
urologist highli incentiv bring case back elsewher
busi compani see sever pocket strength includ growth
march respiratori busi well tailwind
within vascular access help cushion compani disrupt
failur realiz margin expans product recal competit
global diversifi medic technolog product provid
ep estim
debt total capit
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
stock thought share slightli weak today follow solid quarter pull
guidanc name among expens long-term high singl digit larg
cap grower key driver urolift appear like emerg disrupt strong
continu propel stock higher consequ stick ow rate price
target move unchang ep multipl
page
good expens net incom analysi gross analysi vascular inc
million except per share data
good sold
good sold
percent sale
good sold
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
